arrow
P

Pramila Krishnamurthy

the department of haematological medicine
H指数:16
被引数:1,376

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study

DDX41突变髓系肿瘤挑战现有的预后方案,并需要专门的危险评分系统:一项多中心、回顾性研究

Leukemia
IF13.4
2025-12-030
PRE
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS

他米巴罗替与阿扎胞苷联合治疗新诊断高危骨髓增生异常综合征(MDS)的SELECT-MDS-1三期研究的关键结果

2025-05-090
OAAI
Prospective Cohort Study of Non-COVID Infection in Patients with AML/MDS Undergoing Treatment: Implications for Practice

非COVID感染在AML/MDS治疗患者中的前瞻性队列研究:对实践的启示

BLOOD
IF23.1
2024-11-050
PRE
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy
2024-10-250
OAAI
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
2023-11-011
PRE
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
LEUKEMIA
IF13.4
2023-08-0920
OAAI
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
2023-07-1714
OAAI